Status:

RECRUITING

DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma

Lead Sponsor:

Montefiore Medical Center

Collaborating Sponsors:

Johns Hopkins University

Conditions:

Osteosarcoma Recurrent

Ewing's Tumor Recurrent

Eligibility:

All Genders

Up to 39 years

Phase:

PHASE1

PHASE2

Brief Summary

The purpose of this study is to determine the feasibility of administering DFMO to patients with relapsed Ewing sarcoma and osteosarcoma who have completed all planned therapy and have no evidence of ...

Detailed Description

Approximately 30-35% of patients diagnosed with osteosarcoma or Ewing sarcoma will develop relapsed/refractory disease and carry a very poor prognosis. DL-alpha-difluoromethylornithine, commonly known...

Eligibility Criteria

Inclusion

  • Patients \< 40 years of age at the time of enrollment
  • Diagnosis of relapsed osteosarcoma or relapsed Ewing sarcoma who have completed all planned therapy for their relapse, as described in the protocol, and have no evidence of disease
  • Patients must have a performance status corresponding to Eastern Cooperative Oncology Group (ECOG) scores of 0, 1, or 2
  • Adequate bone marrow function defined as:
  • Peripheral absolute neutrophil count (ANC) greater or equal to 750/microliters
  • Platelet count greater or equal to 75,000/microliters (transfusion independent)
  • Adequate renal function defined by serum creatinine based on age and gender
  • Adequate liver function defined as:
  • Total bilirubin ≤ 1.5 x the upper limit of normal (ULN) for age AND
  • SGPT (ALT) ≤ 5.0 x ULN for age. For this study the ULN is 45 U/L

Exclusion

  • Pregnant or breastfeeding females
  • Patients must not have an uncontrolled infection
  • Patients must not have any significant intercurrent illness

Key Trial Info

Start Date :

April 7 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2030

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT06892678

Start Date

April 7 2025

End Date

April 1 2030

Last Update

May 11 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Montefiore Medical Center

The Bronx, New York, United States, 10467